UBS still looking for an out in Genesco deal, O'Charley's plans to tweak its image, Protherics turns in results for the first half of the year and more...
State legislators tussle over how to spend new money from cigarette tax, recently resigned LifePoint CFO's new gig, Luminetx CEO steps aside, Protherics announces full-year results, and more...
Interest expense takes a bite out of CBRL's 3Q results, Fred Thompson closes down old PAC and spreads the wealth, LifePoint looks to offer $500 million worth of notes, and more...
A year after Biomimetic floated shares, a second Nashville-area pharma firm has filed for its initial public offering
HCA plans to sell Miami hospital, Protherics enrolls first patient to test brain tumor treatment, CBRL same-store sales sag in March, a special dividend from Healthcare Realty Trust, and more...
ISS changes tune over Caremark/CVS merger, Plaintiff's attorneys sue each other, Brookdale Senior Living posts widening loss, Protherics receives milestone payment from pharma heavyweight, and more...
A lot of European news for Nashville cos.: Protherics treatment put on fast track for FDA approval, ClientLogic lays off 138 Irish employees, Blavod sees shipment figures rise-remains a buyout target. Also, ex-MBA/Vol fullback expands Franklin-based sports training business to Chattanooga, and more...
Pinnacle's NASDAQ compliance flub causes headache, Va. company to help information flow for Metro Police Dept., Corrections Corp. hopes to better protect inmates from themselves, and more...
British specialty drugmaker with U.S. base in Brentwood has announced $25 million acquisition of Utah company and two new licensing deals
All Articles